Detalles de la búsqueda
1.
Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate.
Rheumatology (Oxford)
; 59(9): 2325-2333, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31859346
2.
Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis.
Rheumatology (Oxford)
; 58(6): 1056-1064, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649524
3.
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
Ann Rheum Dis
; 77(9): 1261-1267, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29760159
4.
Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries.
Rheumatology (Oxford)
; 57(3): 499-507, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244149
5.
Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies.
Rheumatology (Oxford)
; 57(2): 309-317, 2018 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29095992
6.
Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics.
Clin Exp Rheumatol
; 36(6): 976-983, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29745885
7.
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Lancet
; 388(10042): 343-355, 2016 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27287832
8.
Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy.
Rheumatology (Oxford)
; 56(12): 2179-2189, 2017 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29029185
9.
Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis.
Ann Rheum Dis
; 78(1): 142-144, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30158123
10.
Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries.
Rheumatology (Oxford)
; 57(6): 1129, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29635639
11.
Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials.
Arthritis Care Res (Hoboken)
; 74(6): 889-895, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253497
12.
Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis.
BMJ Open
; 11(6): e042246, 2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135030
13.
Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis.
J Patient Rep Outcomes
; 5(1): 69, 2021 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373947
14.
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis.
J Rheumatol
; 48(4): 495-503, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32739893
15.
Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab.
PLoS One
; 15(12): e0241189, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301475
16.
Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis.
Arthritis Care Res (Hoboken)
; 71(4): 498-511, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29856128
17.
Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.
Arthritis Res Ther
; 20(1): 230, 2018 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30322408
18.
Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy.
Arthritis Res Ther
; 19(1): 170, 2017 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728565
Resultados
1 -
18
de 18
1
Próxima >
>>